Form D · Biotechnology
Orpheris, Inc.
Redwood City, CA · CIK 0001671789
Offering snapshot reported Jun 13, 2016 · SEC filing
- Reported sold
- $190 Offering amount: $190
- Investors reported
- 3 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Jun 1, 2016 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Jun 13, 2016 | Initial | $190 | No comparison | 3 | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-264868
Source: Form D, filed Jun 13, 2016. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Jeffrey Cleland | Director, Executive |
| Justin Hanes | Director, Executive |
| Sujatha Kannan | Director, Executive |
| Kannan Rangaramanujam | Director, Executive |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
303 Twin Dolphin Drive, Suite 600
Redwood City, CA, 94065
Redwood City, CA, 94065